​

Tonix Pharmaceuticals (TNXP) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Tonix Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$10.09M

Latest Revenue (Q)

$2.43M

Tonix Pharmaceuticals Revenue by Period

Tonix Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$10.09M29.94%
2023-12-31$7.77M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Tonix Pharmaceuticals generated $10.09M in revenue during NA 2024, up 29.94% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Tonix Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-03-31$2.43M-5.93%
2024-12-31$2.58M-8.50%
2024-09-30$2.82M27.81%
2024-06-30$2.21M-11.04%
2024-03-31$2.48M-108.24%
2023-12-31$-30.12M-855.15%
2023-09-30$3.99M100.00%
2023-06-30--100.00%
2023-03-31$33.90M100.00%
2022-12-31-100.00%
2022-09-30--100.00%
2022-06-30$9.03M100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$2.91M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$-500.00100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31--

Tonix Pharmaceuticals generated $2.43M in revenue during Q1 2025, up -5.93% compared to the previous quarter, and up -8.06% compared to the same period a year ago.

Tonix Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IPHAInnate Pharma$51.90M$16.56M
FATEFate Therapeutics$13.63M$1.91M
TNXPTonix Pharmaceuticals$10.09M$2.43M
APLTApplied Therapeutics$455.00K-
AVTXAvalo Therapeutics$441.00K-
MCRBSeres Therapeutics--
FBRXForte Biosciences--
ELTXElicio Therapeutics--
NKTXNkarta--
MISTMilestone Pharmaceuticals--
ELDNEledon Pharmaceuticals--

TNXP Revenue FAQ

What is Tonix Pharmaceuticals’s yearly revenue?

Tonix Pharmaceuticals's yearly revenue for 2024 was $10.09M, representing an increase of 29.94% compared to 2023. The company's yearly revenue for 2023 was $7.77M, representing an increase of 100.00% compared to 2022. TNXP's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Tonix Pharmaceuticals’s quarterly revenue?

Tonix Pharmaceuticals's quarterly revenue for Q1 2025 was $2.43M, a -5.93% decrease from the previous quarter (Q4 2024), and a -2.14% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $2.58M, a -8.50% decrease from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). TNXP's quarterly revenue for Q3 2024 was $2.82M, a 27.81% increase from the previous quarter (Q2 2024), and a -29.26% decrease year-over-year (Q3 2023).

What is Tonix Pharmaceuticals’s revenue growth rate?

Tonix Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.